SCHEMBL22041596

SCHEMBL22041596

COc1ccc(C(=O)Oc2cccc3cc(C(=O)O)c(=O)oc23)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.73
CA1 P00915 1/20 0.73
CA2 P00918 1/20 0.73
CA3 P07451 1/20 0.73
CA4 P22748 1/20 0.73
CA6 P23280 1/20 0.73
CA5A P35218 1/20 0.73
CA7 P43166 1/20 0.73
CA9 Q16790 1/20 0.73
CA14 Q9ULX7 1/20 0.73
CA5B Q9Y2D0 1/20 0.73
MAPT P10636 5/20 0.66
POLB P06746 3/20 0.65
ALDH1A1 P00352 5/20 0.62
RXFP1 Q9HBX9 1/20 0.61
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
RAB9A P51151 3/20 0.59
KDM4E B2RXH2 1/20 0.59
PLIN1 O60240 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041601 0.88 CA12 (0.71) CA12CA1CA2CA3CA4
SCHEMBL980310 0.85 CA12 (1.00) CA12CA1CA2CA3CA4
Hydrochloric Acid SCHEMBL11339314 0.84 CA12 (0.97) CA12CA1CA2CA3CA4
SCHEMBL11347549 0.81 CA12 (0.77) CA12CA1CA2CA3CA4
SCHEMBL22041621 0.77 CA12 (0.70) CA12CA1CA2CA3CA4
SCHEMBL28445182 0.76 CA12 (0.77) CA12CA1CA2CA3CA4
SCHEMBL2034208 0.76 CA12 (0.76) CA12CA1CA2CA3CA4
SCHEMBL7519005 0.75 CA12 (0.79) CA12CA1CA2CA3CA4
SCHEMBL19656170 0.75 ESR1 (0.66) CA1CA2MAPTPOLBALDH1A1
SCHEMBL28155268 0.75 CA12 (0.74) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 WO disclosed